TrademarkDir
K
LIVE

Serial Number

97833358

Owner

Kriya Therapeutics, Inc.

Attorney

Monica Riva Talley

Filing Date

Mar 10, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

K Trademark

Serial Number: 97833358

K is a trademark filed by Kriya Therapeutics, Inc. on March 10, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Kriya Therapeutics, Inc. (24 trademarks)

Palo Alto, CA 94306

Entity Type: 03

Trademark Details

Filing Date

March 10, 2023

Registration Date

Not Registered

Published for Opposition

April 9, 2024

Goods & Services

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders

Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, viral, neurological, gastrointestinal, hormonal, dermatological, and immune-system-related diseases and disorders

Biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process; providing technical information in the field of pharmaceutical manufacturing

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 3, 2025 EXRA
SOU EXTENSION 3 GRANTED
Dec 2, 2025 EX3G
SOU EXTENSION 3 FILED
Dec 2, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 2, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 1, 2025 EXRA
SOU EXTENSION 2 GRANTED
May 1, 2025 EX2G
SOU EXTENSION 2 FILED
Apr 30, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 30, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 31, 2024 EXRA
SOU EXTENSION 1 GRANTED
Oct 31, 2024 EX1G
SOU EXTENSION 1 FILED
Oct 31, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 31, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 4, 2024 NOAM
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 23, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 23, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 23, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 23, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 23, 2024 COAR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 4, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 1, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 1, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 1, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 1, 2024 CNEA
ASSIGNED TO EXAMINER
Mar 1, 2024 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 7, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 7, 2023 GNRT
NON-FINAL ACTION WRITTEN
Dec 7, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 7, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 31, 2023 NWOS
NEW APPLICATION ENTERED
Mar 14, 2023 NWAP

Related Trademarks

More from this Owner

GENE THERAPY. REDEFINED.

GENE THERAPY. REDEFINED.

GENE THERAPY. REDEFINED.

GENE THERAPY. REDEFINED.

KRIYA METABOLIC

KRIYA METABOLIC

KRIYA METABOLIC

KRIYA METABOLIC

KRIYA NEUROLOGY

KRIYA NEUROLOGY

KRIYA NEUROLOGY

KRIYA NEUROLOGY